Medicare Enrolled

Dr. Yuvraj Kumbkarni, M.D.

Endocrinology · Tampa, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
14014 N 46TH ST STE B, Tampa, FL 33613
8139772020
In practice since 2005 (20 years)
NPI: 1720076177 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kumbkarni from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kumbkarni? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kumbkarni

Dr. Yuvraj Kumbkarni is an endocrinology in Tampa, FL, with 20 years in practice. Based on federal Medicare data, Dr. Kumbkarni performed 1,178 Medicare services across 883 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kumbkarni received a total of $173,140 from 76 pharmaceutical and/or device companies across 1783 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kumbkarni is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 39% volume in FL$ $173,140 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,178
Medicare services
Top 39% in FL for endocrinology
883
Unique beneficiaries
$66
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~59 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)425$92$273
Office visit, established patient (20-29 min)145$65$186
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report142$26$91
Blood glucose (sugar) test performed by hand-held instrument89$3$8
Hemoglobin A1c test (diabetes monitoring)60$9$27
Blood draw (venipuncture)59$8$19
Ultrasound scan of head and neck soft tissue59$78$283
New patient office visit (45-59 min)34$124$415
Office visit, established patient, complex (40-54 min)30$132$366
Telephone medical discussion with physician, 11-20 minutes29$70$230
Fine needle aspiration biopsy using ultrasound guidance, first growth27$98$320
Hospital follow-up visit, moderate complexity23$63$186
Initial hospital admission, moderate complexity22$103$350
Telephone medical discussion with physician, 21-30 minutes22$99$326
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin12$46$135
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$173,140
Total received (2018-2024)
Avg $24,734/year across 7 years
Top 6% in FL for endocrinology
76
Companies
1,783
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$130,099 (75.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$29,097 (16.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$13,756 (7.9%)
Other
Charitable contributions, space rental, and other categories
$187 (0.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$36,972
2023
$21,285
2022
$28,701
2021
$15,302
2020
$20,810
2019
$14,896
2018
$35,172

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Boehringer Ingelheim Pharmaceuticals, Inc.
$33,996
Lilly USA, LLC
$33,446
SANOFI-AVENTIS U.S. LLC
$27,823
AstraZeneca Pharmaceuticals LP
$17,341
Corcept Therapeutics
$14,737
Xeris Pharmaceuticals, Inc.
$8,646
Intuity Medical Inc
$7,633
Novo Nordisk Inc
$5,243
IBSA Pharma Inc.
$3,602
Medtronic, Inc.
$2,983
Amgen Inc.
$2,096
Insulet Corporation
$787
Abbott Laboratories
$704
ABBVIE INC.
$698
Antares Pharma, Inc.
$677
Dexcom, Inc.
$668
Bayer Healthcare Pharmaceuticals Inc.
$658
Bayer HealthCare Pharmaceuticals Inc.
$611
Mannkind Corporation
$600
AbbVie, Inc.
$554
Amarin Pharma Inc.
$524
CeQur Corporation
$509
Radius Health, Inc.
$494
Horizon Therapeutics plc
$474
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$435
Valeritas, Inc.
$361
Janssen Pharmaceuticals, Inc
$352
RECORDATI_RARE_DISEASES_INC.
$346
Merck Sharp & Dohme Corporation
$338
MannKind Corporation
$329
Senseonics, Incorporated
$320
Amryt Pharma Holdings Ltd
$316
Kyowa Kirin, Inc.
$292
Amneal Pharmaceuticals LLC
$271
Ascensia Diabetes Care Us Inc.
$270
Kowa Pharmaceuticals America, Inc.
$258
Tandem Diabetes Care, Inc.
$251
Zealand Pharma US, Inc.
$248
Aytu BioScience, Inc
$246
Medtronic MiniMed, Inc.
$201
AbbVie Inc.
$196
DEXCOM, INC.
$190
Shire North American Group Inc
$182
Nevro Corp.
$172
PFIZER INC.
$138
Alexion Pharmaceuticals, Inc.
$129
EISAI INC.
$121
Esperion Therapeutics, Inc.
$119
Astellas Pharma US Inc
$119
LIFESCAN, INC.
$118
Acerus Pharmaceuticals Corporation
$118
Supernus Pharmaceuticals, Inc.
$107
Allergan Inc.
$99
VIVUS, Inc.
$94
BETA BIONICS, INC.
$94
Companion Medical, Inc.
$77
Merck Sharp & Dohme LLC
$70
Ipsen Biopharmaceuticals, Inc
$70
Renalytix AI, Inc.
$61
Almatica Pharma LLC
$60
LifeScan, Inc.
$59
Ultragenyx Pharmaceutical Inc.
$54
Novartis Pharmaceuticals Corporation
$52
EUSA Pharma (US) LLC
$49
Tolmar, Inc.
$43
Avvisto Therapeutics, LLC
$34
Neurocrine Biosciences, Inc.
$25
Regeneron Healthcare Solutions, Inc.
$21
Aegerion Pharmaceuticals, Inc.
$20
Roche Diabetes Care, Inc.
$20
Axonics, Inc.
$18
Intra-Sana Laboratories
$17
Clarus Therapeutics Inc.
$16
VIVUS LLC
$15
Ferring Pharmaceuticals Inc.
$14
Currax Pharmaceuticals LLC
$12
Top 3 companies account for 55.0% of total payments
Associated products mentioned in payments ›
AFREZZA · Accu-Chek Guide · Androgel · Axonics r-SNM System · BAQSIMI · BASAGLAR · BYDUREON · CONTRAVE · CREON · CYCLOSET · CeQur Simplicity · Creon · Crysvita · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · Dexcom CGM · Dexcom G6 Transmitter · ENTRESTO · EVENITY · EVERSENSE 365 SENSOR KIT (RETAIL) · EVERSENSE E3 SENSOR KIT - RETAIL · EVERSENSE E3 SMART TRANSMITTER KIT · EVKEEZA · Eversense · FARXIGA · FIASP · FORTEO · FREESTYLE COPILOT · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre blood glucose Flash Monitoring System · GLYXAMBI · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · HUMULIN R 500 · HUMULIN U · INPEN SMART INSULIN DELIVERY SYSTEM · INVOKANA · ISTURISA · InPen · JANUVIA · JARDIANCE · JATENZO · JUXTAPID · KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT · Kerendia · Korlym · LICART · LYRICA · LYUMJEV · Lenvima · Licart · Livalo · MINIMED 770G · MINIMED 780G · MOUNJARO · MYALEPT · MYCAPSSA · Minimed 670G System · Mirena · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · NOCDURNA · Natesto · ONETOUCH VERIO FLEX · OT Verio Reflect "One Touch Meter and Strips" · OTREXUP · Omnia · Omnipod · OneTouch Verio Reflect · Ozempic · PRADAXA · PRALUENT · Pogo Automatic Blood Glucose Monitoring System · Prolia · QSYMIA · RECORLEV · RELTONE 200 MG · REVEAL LINQ · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMATULINE DEPOT · SOMAVERT · STEGLATRO · STEGLUJAN · STRENSIQ · SYNJARDY · SYNTHROID · Saxenda · Senza · Sylvant · Synthroid · TEPEZZA · TERIPARATIDE · TLANDO · TOUJEO · TOVIAZ · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tresiba · Tymlos · UBRELVY · UNITHROID · V-GO · V-GO DISPOSABLE INSULIN DELIVERY · VRAYLAR · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XIFAXAN · XYOSTED · Xultophy 100/3.6 · ZEGALOGUE · ZOMACTON · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (75%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in endocrinology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 6% for endocrinology in FL.

Equivalent to $14,698 per 100 Medicare services performed
Looking for a endocrinology in Tampa?
Compare endocrinologys in the Tampa area by procedure volume, costs, and industry payment transparency.
Browse endocrinologys nearby

Geographic Context

Endocrinologys within 10 mi
74
Per 100K population
5.0
County median income
$75,011
Nearest hospital
ADVENTHEALTH TAMPA
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Kumbkarni is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (speaking/promotional, top 6%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Kumbkarni experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Kumbkarni performed 425 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kumbkarni receive payments from pharmaceutical companies?
Yes. Dr. Kumbkarni received a total of $173,140 from 76 companies across 1,783 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kumbkarni's costs compare to other endocrinologys in Tampa?
Dr. Kumbkarni's average Medicare payment per service is $66. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kumbkarni) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →